HomeInsights52 Week High Stocks

Shukra Pharmaceuticals Ltd 52 Week High

Shukra Pharmaceuticals Ltd 52 Week High

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Nov 25, 2024)

stocks purchased

9.3 K

Stocks Traded

(Nov 25, 2024)

Last Updated on: Nov 25, 2024

Image

Shukra Pharmaceuticals Ltd

NSE: SHUKRAPHARMA

YEARHIGH

₹ 129.9

Last updated on: Nov 22, 2024

Key Highlights

  • The 52 Week HIGH of Shukra Pharmaceuticals Ltd is ₹ 129.9 as of 22 Nov 24 .

Company Fundamentals for Shukra Pharmaceuticals Ltd

No data available

Market Price of Shukra Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Shukra Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202458.9
21 Nov 202458.28
19 Nov 202460.39
18 Nov 202462.68
14 Nov 202465.97
13 Nov 202464.93
12 Nov 202466.36
11 Nov 202469.15
08 Nov 202466.08
07 Nov 202467.87

Asset Value vs Market Value of Shukra Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Shukra Pharmaceuticals Ltd News Hub

News

Shukra Pharmaceuticals to discuss results

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 ...

Read more

08 Nov 202417:22

News

Shukra Pharmaceuticals schedules board meeting

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 ...

Read more

24 Sep 202410:28

News

Shukra Pharmaceuticals to hold AGM

Shukra Pharmaceuticals announced that the 31th Annual General Meeting (AGM) of the company...

Read more

16 Sep 202410:13

News

Shukra Pharmaceuticals to discuss results

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 ...

Read more

05 Aug 202410:57

News

Shukra Pharmaceuticals schedules EGM

Shukra Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Compa...

Read more

31 Jul 202417:47

News

Board of Shukra Pharmaceuticals recommends final dividend

Shukra Pharmaceuticals announced that the Board of Directors of the Company at its meeting...

Read more

30 May 202412:16

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Shukra Pharmaceuticals Ltd

What is the significance of Shukra Pharmaceuticals Ltd reaching its 52-week high?

Shukra Pharmaceuticals Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Shukra Pharmaceuticals Ltd 52-week high?

Investors monitor Shukra Pharmaceuticals Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Shukra Pharmaceuticals Ltd a good buy when it hits its 52-week high?

Whether Shukra Pharmaceuticals Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Shukra Pharmaceuticals Ltd fundamentals.

What should I consider before investing in Shukra Pharmaceuticals Ltd at its 52-week high?

Before investing in Shukra Pharmaceuticals Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Shukra Pharmaceuticals Ltd stock price continue to rise after reaching its 52-week high?

Shukra Pharmaceuticals Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*